Novel dual CAFs and tumour cell targeting pH and ROS dual sensitive micelles for targeting delivery of paclitaxel to liver cancer

References

• Eso Y, Marusawa H. Novel approaches for molecular targeted therapy against hepatocellular carcinoma. Hepatol Res. 2018;48:597–607.
   PubMed Web of Science ®Google Scholar
• Taitt HE. Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Mens Health. 2018;12:1807–1823.
   PubMed Web of Science ®Google Scholar
• Fernandes C, Suares D, Yergeri MC. Tumor microenvironment targeted nanotherapy. Front Pharmacol. 2018;9:1230.
   PubMed Web of Science ®Google Scholar
• Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discovery. 2019;18:99–115.
   PubMed Web of Science ®Google Scholar
• Jacobetz MA, Chan DS, Neesse A, et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut. 2013;62:112–120.
   PubMed Web of Science ®Google Scholar
• Wong KM, Horton KJ, Coveler AL, et al. Targeting the tumor stroma: the biology and clinical development of pegylated recombinant human hyaluronidase (PEGPH20. Current Oncology Reports. 2017;19:1–9.
   PubMed Web of Science ®Google Scholar
• Ishii G, Ochiai A, Neri S. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. Adv Drug Deliv Rev. 2016;99(Pt B):186–196.
   PubMedGoogle Scholar
• Santos AM, Jung J, Aziz N, et al. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. The Journal of Clinical Investigation. 2009;119:3613–3625.
   PubMed Web of Science ®Google Scholar
• Bhuvaneswari R, Ng QF, Thong PS, et al. Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model. Oncotarget. 2015;6:13487.
   PubMedGoogle Scholar
• Gollnick SO, Brackett CM. Enhancement of anti-tumor immunity by photodynamic therapy. Immunol Res. 2010;46(1-3):216–226.
   PubMed Web of Science ®Google Scholar
• Fang J, Xiao L, Joo KI, et al. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice. Int J Cancer. 2016;138:1013–1023.
   PubMed Web of Science ®Google Scholar
• Ji T, Zhao Y, Ding Y, et al. Transformable peptide nanocarriers for expeditious drug release and effective cancer therapy via cancer‐associated fibroblast activation. Angewandte Chemie. 2016;128:1062–1067.
   Google Scholar
• Liu M, Song W, Huang L. Drug delivery systems targeting tumor-associated fibroblasts for cancer immunotherapy. Cancer Letters. 2019;448:31–39.
   PubMed Web of Science ®Google Scholar
• Chen B, Dai W, Mei D, et al. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system. J Control Release. 2016;241:68–80.
   PubMed Web of Science ®Google Scholar
• Wang J, Li Q, Li X, et al. A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy. Eur J Pharmacol. 2017;815:166–172.
   PubMed Web of Science ®Google Scholar
• Rehman A, Jafari SM, Tong Q, et al. Drug nanodelivery systems based on natural polysaccharides against different diseases. Adv Colloid Interface Sci. 2020;284:102251.
   PubMed Web of Science ®Google Scholar
• Naveen C, Shastri N R. Polysaccharide nanomicelles as drug carriers[M]//Polysaccharide Carriers for Drug Delivery. Woodhead Publishing, 2019: 339–363.
   Google Scholar
• Zheng Y, Xie Q, Wang H, et al. Recent advances in plant polysaccharide-mediated nano drug delivery systems. Int J Biol Macromol. 2020;165(Pt B):2668–2683.
   PubMedGoogle Scholar
• Zhang X, Zhao M, Cao N, et al. Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment. Biomater Sci. 2020;8:1885–1896.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu F, Ding Y, et al. Preparation and characterization of paclitaxel/chitosan nanosuspensions for drug delivery system and cytotoxicity evaluation in vitro. Advanced Fiber Materials. 2019;1:152–162.
   Google Scholar
• Clement J, Rae A. Therapeutic drug combinations and delivery systems comprising c-raf kinase antisense polynucleotides for treating ocular diseases and disorders: U.S. Patent Application 11/753,900[P]. 2007-11-29.
   Google Scholar
• Guo C, Hou X, Liu Y, et al. Novel chinese angelica polysaccharide biomimetic nanomedicine to curcumin delivery for hepatocellular carcinoma treatment and immunomodulatory effect. Phytomedicine. 2021;80:153356.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xiao J, Duan Y, et al. Lycium barbarum polysaccharide ameliorates sjögren’s syndrome in a murine model. Mol Nutr Food Res. 2021;65(11):2001118.
   Web of Science ®Google Scholar
• Chen D, Lian S, Sun J, et al. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition. Drug Deliv. 2016;23:798–803.
   Web of Science ®Google Scholar
• Spadea A, Rios de la Rosa JM, Tirella A, et al. Evaluating the efficiency of hyaluronic acid for tumor targeting via CD44. Mol Pharmac. 2019;16:2481–2493.
   PubMed Web of Science ®Google Scholar
• Bousoik E, Qadri M, Elsaid KA. CD44 receptor mediates urate crystal phagocytosis by macrophages and regulates inflammation in a murine peritoneal model of acute gout. Sci Rep. 2020;10:1–15.
   PubMed Web of Science ®Google Scholar
• Thorne RF, Wang Y, Zhang Y, et al. Evaluating nuclear translocation of surface receptors: recommendations arising from analysis of CD44. Histochem Cell Biol. 2020;153:77–87.
   PubMed Web of Science ®Google Scholar